Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and Ebola

Project Information

ECRC

Grant agreement ID: 857934

DOI

10.3030/857934

Project closed

EC signature date 16 July 2019

Start date 1 January 2019

End date 29 February 2024

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

€ 51 428 572,00

EU contribution

€ 36 000 000,00

Coordinated by

COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS
Norway